News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Pays $450 Million to Brigham Young University Over Celebrex Spat


5/2/2012 7:05:49 AM

To put an end to what could have been an embarrassing and potentially costly episode, Pfizer has agreed to pay $450 million to Brigham Young University and endow a chair in the name of Daniel Simmons, a professor who claimed the drugmaker wrongfully cheated him out of money and credit for research that led to the discovery and commercialization of the best-selling Celebrex painkiller (see page 13 here). A trial had been scheduled to begin later this month. Simmons maintained that he discovered the Cox-2 enzyme in 1991 that evolved into Celebrex and that the university signed a research agreement with Monsanto, which later became part of the big drugmaker. However, Simmons and BYU charged the deal was “fraudulently” ended without compensation, a former Monsanto chief scientific officer took credit for the discovery and that Simmons’ work was used as a roadmap for developing the painkiller (here is the lawsuit).

Read at Pharmalot
Read at Salt Lake Tribune
Read at AP
Read at Washington Post

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES